Efficient, repeated adenovirus-mediated gene transfer in mice lacking both tumor necrosis factor alpha and lymphotoxin α

Journal of Virology

Volumn 72, Issue 12, 1998, Pages 9514-9525

  Benihoud, Karim ^a   Saggio, Isabella ^b   Opolon, Paule ^a   Salone, Barbara ^b   Amiot, Franck ^c   Connault, Elisabeth ^a   Chianale, Colette ^a   Dautry, François ^c   Yeh, Patrice ^a   Perricaudet, Michel ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c Institut de Recherche sur le Cancer   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTERLEUKIN 6; LYMPHOTOXIN; NEUTRALIZING ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; VIRUS ANTIBODY; VIRUS ANTIGEN; VIRUS VECTOR;

ACUTE PHASE RESPONSE; ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; GENE TRANSFER; IMMUNE DEFICIENCY; KNOCKOUT MOUSE; LIVER; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TRANSGENE;

EID: 0031775491     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.12.9514-9525.1998     Document Type: Article

References (64)

1. Amiot, F., O. Boussadia, S. Cases, C. Fitting, M. Lebastard, J.-M. Cavaillon, G. Milon, and F. Dautry. 1997. Mice heterozygous for a deletion of the tumor necrosis factor-alpha and lymphotoxin-alpha genes: biological importance of a nonlinear response of tumor necrosis factor-alpha to gene dosage. Eur. J. Immunol. 27:1035-1042.
2. + T cell clones provides a costimulatory signal for human B cell activation. J. Exp. Med. 177: 1575-1585.
3. Banks, T. A., B. T. Rouse, M. K. Kerley, P. J. Blair, V. L. Godfrey, N. A. Kuklin, D. M. Bouley, J. Thomas, S. Kanangat, and M. L. Mucenski. 1995. Lymphotoxin-alpha-deficient mice. Effects on secondary lymphoid organ development and humoral immune responsiveness. J. Immunol. 155:1685-1693.
4. Barr, D., J. Tubb, D. Fergusson, A. Scaria, A. Lieber, C. Wilson, J. Perkins, and M. A. Kay. 1995. Strain-related variations in adenoviral mediated transgene expression from mouse hepatocytes in vivo: comparisons between immunocompetent and immunodeficient inbred strains. Gene Ther. 2:151-155.
5. Browning, J. L., A. Ngam-Ek, P. Lawton, J. DeMarinis, R. Tizard, E. P. How, C. Hession, B. O'Brine-Greco, S. F. Foley, and C. F. Ware. 1993. Lymphotoxin-beta, a novel member of the TNF family forms a heteromeric complex with lymphotoxin on the cell surface. Cell 72:847-856.
6. Bruder, J. T., T. Jie, D. L. McVey, and I. Kovesdi. 1997. Expression of gp19k increases the persistence of transgene expression from an adenovirus vector in the mouse lung. J. Virol. 71:7623-7628.
7. Chen, P., J. Tian, I. Kovesdi, and J. T. Bruder. 1998. Interaction of the adenovirus 14.7-kDa protein with FLICE inhibits Fas Ligand-induced apootosis. J. Biol. Chem. 273:5815-5820.
8. Crowe, P. D., T. L. VanArsdale, B. N. Walter, C. F. Ware, C. Hession, B. Ehrenfels, J. L. Browning, W. S. Din, R. G. Goodwin, and C. A. Smith. 1994. A lymphotoxin-beta specific receptor. Science 264:707-710.
9. Dai, Y., E. M. Schwarz, D. Gu, W.-W. Zhang, N. Sarvetnick, and I. M. Verma. 1995. Cellular and humoral responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long term expression. Proc. Natl. Acad. Sci. USA 92:1401-1405.
10. De Matteo, R. P., G. Chu, M. Ahn, E. Chang, C. F. Barker, and J. F. Markmann. 1997. Long-lasting adenovirus transgene expression in mice through neonatal intrathymic tolerance induction without the use of immunosuppression. J. Virol. 71:5330-5335.
11. Dedieu, J.-F., E. Vigne, C. Torrent, C. Jullien, I. Mahfouz, J.-M. Caillaud, N. Aubailly, C. Orsini, J.-M. Guillaume, P. Opolon, P. Delaère, M. Perricaudet, and P. Yeh. 1997. Long-term gene delivery into the livers of immunocompetent mice with E1/E4-defective adenoviruses. J. Virol. 71:4626-4637.
12. + T cell clones. J. Immunol. 152:4872-4879.
13. Dimitrov, T., P. Krajcsi, T. W. Hermiston, A. E. Tollefson, M. Hannink, and W. S. M. Wold. 1997. Adenovirus E3-10.4K/14.5K protein complex inhibits tumor necrosis factor-induced translocation of cytosolic phospholipase A2 to membranes. J. Virol. 71:2830-2837.
14. Dong, J.-Y., D. Wang, F. W. Van Ginkel, D. W. Pascual, and R. A. Frizzell. 1996. Systematic analysis of repeated gene delivery into animal lungs with a recombinant adenovirus vector. Hum. Gene Ther. 7:319-331.
15. Elkon, K. B., C.-C. Liu, J. G. Gall, J. Trevejo, M. W. Marino, K. A. Abrahamsen, X. Song, J.-L. Zhou, L. J. Old, R. G. Crystal, and E. Falck-Pedersen. 1997. Tumor necrosis factor alpha plays a central role in immune-mediated clearance of adenoviral vectors. Proc. Natl. Acad. Sci. USA 94: 9814-9819.
16. Engelhardt, J. F., X. Ye, B. Doranz, and J. M. Wilson. 1994. Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc. Natl. Acad. Sci. USA 91:6196-6200.
17. Eugster, H.-P., M. Müller, U. Karrer, B. D. Car, M. Schnyder, V. M. Eng, G. Woerly, M. Le Hir, F. di Padova, M. Aguet, R. Zinkernagel, H. Bluethmann, and B. Ryffel. 1996. Multiple immune abnormalities in tumor necrosis factor and lymphotoxin-alpha double deficient-mice. Int. Immunol. 8:23-36.
18. Fallaux, F. J., O. Kranenburg, S. J. Cramer, A. Houweling, H. van Ormondt, R. C. Hoeben, and A. J. van der Eb. 1996. Characterization of 911: a new helper cell line for the titration and propagation of early-region-1-deleted adenoviral vectors. Hum. Gene Ther. 7:215-222.
19. Gahéry-Ségard, H., V. Juillard, J. Gaston, R. Lengagne, A. Pavirani, P. Boulanger, and J.-G. Guillet. 1997. Humoral immune response to the capsid components of recombinant adenoviruses: routes of immunization modulate virus-induced Ig subclass shifts. Eur. J. Immunol. 27:653-659.
20. Gao, G.-P., Y. Yang, and J. M. Wilson. 1996. Biology of adenovirus vectors with E1 and E4 deletions for liver-directed gene therapy. J. Virol. 70:8934-8943.
21. Ghiara, P., D. Boraschi, L. Nencioni, P. Ghezzi, and A. Tagliabue. 1987. Enhancement of in vivo immune response by tumor necrosis factor. J. Immunol. 139:3676-3679.
22. Gilardi, P., M. Courtney, A. Pavirani, and M. Perricaudet. 1990. Expression of human alpha-1 antitrypsin using a recombinant adenovirus vector. FEBS Lett. 267:60-62.
23. Ginsberg, H. S., U. Lundholm-Beauchamp, R. L. Horswood, B. Pernis, W. S. M. Wold, R. M. Chanock, and G. A. Prince. 1989. Role of early region 3 (E3) in pathogenesis of adenovirus disease. Proc. Natl. Acad. Sci. USA 86: 3823-3827.
24. Ginsberg, H. S., L. L. Moldawer, P. Sehgal, M. Redington, P. L. Kilian, R. M. Chanock, and G. A. Prince. 1991. A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia. Proc. Natl. Acad. Sci. USA 88:1651-1655.
25. Grell, M., E. Douni, H. Wajant, M. Löhden, M. Clauss, B. Maxeiner, S. Georgopoulos, W. Lesslauer, G. Kollias, K. Pfizenmaier, and P. Scheurich. 1995. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80kDa tumor necrosis factor receptor. Cell 83:793-802.
26. Griscelli, F., H. Li, A. Bennaceur-Griscelli, J. Soria, P. Opolon, C. Soria, M. Perricaudet, P. Yeh, and H. Lu. 1998. Angiostatin gene transfer: inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrest. Proc. Natl. Acad. Sci. USA 95:6367-6372.
27. Ilan, Y., G. Droguett, N. Roy Chowdhury, Y. Li, K. Sengupta, N. R. Thummala, A. Davidson, J. Roy Chowdhury, and M. S. Horwitz. 1997. Insertion of the adenoviral E3 region into a recombinant viral vector prevents antiviral humoral and cellular immune responses and permits long-term gene expression. Proc. Natl. Acad. Sci. USA 94:2587-2592.
28. Ilan, Y., R. Prakash, A. Davidson, V. Jona, G. Droguett, S. M. Horwitz, N. R. Chowdhury, and J. R. Chowdhury. 1997. Oral tolerization to adenoviral antigens permits long-term gene expression using recombinant adenoviral vectors. J. Clin. Invest. 99:1098-1106.
29. Kochanek, S., P. R. Clemens, K. Mitani, H. H. Chen, S. Chan, and C. T. Caskey. 1996. A new adenoviral vector: replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase. Proc. Natl. Acad. Sci. USA 93:5731-5736.
30. Krajcsi, P., A. E. Tollefson, C. W. Anderson, and W. S. M. Wold. 1992. The adenovirus E3 14.5-kDa protein, which is required for down-regulation of the epidermal growth factor receptor and prevention of tumor necrosis factor cytolysis, is an integral membrane protein oriented with its C terminus in the cytoplasm. J. Virol. 66:1665-1673.
31. Kuzmin, A. I., M. J. Finegold, and R. C. Eisensmith. 1997. Macrophage depletion increases the safety, efficacy and persistence of adenovirus-mediated gene transfer in vivo. Gene Ther. 4:309-316.
32. Laster, S. M., W. S. M. Wold, and L. R. Gooding. 1994. Adenovirus proteins that regulate susceptibility to TNF also regulate the activity of PLA2. Semin. Virol. 5:431-442.
33. Le Hir, M., H. Bluethmann, M. H. Kosco-Villebois, M. Muller, F. di Padova, M. Moore, B. Ryffel, and H.-P. Eugster. 1996. Differentiation of follicular dendritic cells and full antibody responses require tumor necrosis factor receptor-1 signaling. J. Exp. Med. 183:2367-2372.
34. Lee, M. G., M. A. Abina, H. Haddada, and M. Perricaudet. 1995. The constitutive expression of the immunomodulatory gp19k protein in E1-, E3-adenoviral vectors strongly reduces the host cytotoxic T cell response against the vector. Gene Ther. 2:1-7.
35. Lens, S. M. A., K. Tesselaar, B. F. A. Den Drijver, M. H. J. Van Oers, and R. A. W. Van Lier. 1996. A dual role for both CD40-ligand and TNF alpha in controlling human B cell death. J. Immunol. 156:507-514.
36. Lieber, A., C.-Y. He, I. Kirillova, and M. A. Kay. 1996. Recombinant adenoviruses with large deletions generated by Cre-mediated excision exhibit different biological properties compared with first-generation vectors in vitro and in vivo. J. Virol. 70:8944-8960.
37. Macchia, D., F. Almerigogna, P. Parronchi, A. Ravina, E. Maggi, and S. Romagnani. 1993. Membrane tumor necrosis factor alpha is involved in the polyclonal B-cell activation induced by HIV-infected human T cells. Nature 363:464-466.
38. Mackay, F., G. R. Majeau, P. Lawton, P. S. Hochman, and J. L. Browning. 1997. Lymphotoxin but not tumor necrosis factor functions to maintain splenic architecture and humoral responsiveness in adult mice. Eur. J. Immunol. 27:2033-2042.
39. Marino, M. W., A. Dunn, D. Grail, M. Inglese, Y. Noguchi, E. Richards, A. Jungbluth, H. Wada, M. Moore, B. Williamson, S. Basu, and L. J. Old. 1997. Characterization of tumor necrosis factor-deficient mice. Proc. Natl. Acad. Sci. USA 94:8093-8098.
40. McCoy, R. D., B. L. Davidson, B. J. Roessler, G. B. Huffnagle, S. L. Janich, T. J. Laing, and R. H. Simon. 1995. Pulmonary inflammation induced by incomplete or inactivated adenoviral particles. Hum. Gene Ther. 6:1553-1560.
41. Mencacci, A., E. Cenci, G. Del Sero, C. Fe d'Ostiani, P. Mosci, C. Montagnoli, A. Bacci, F. Bistoni, V. F. Quesniaux, B. Ryffel, and L. Romani. 1998. Defective co-stimulation and impaired Th1 development in tumor necrosis factor/lymphotoxin-alpha double-deficient mice infected with Candida albicans. Int. Immunol. 10:37-48.
42. Michalski, J. P., C. C. McCombs, S. Sheth, M. McCarthy, and R. deShazo. 1985. A modified double antibody sandwich enzyme-linked immunosorbent assay for measurement of alpha-1-antitrypsin in biologic fluids. J. Immunol. Methods 83:101-112.
43. Mortensen, R. F., J. Shapiro, B.-F. Lin, S. Douches, and R. Neta. 1988. Interaction of recombinant IL-1 and recombinant tumor necrosis factor in the induction of mouse acute phase proteins. J. Immunol. 140:2260-2266.
44. Neumann, B., T. Machleidt, A. Lifka, K. Pfeffer, D. Vestweber, T. W. Mak, B. Holzmann, and M. Krönke. 1996. Crucial role of 55-kilodalton TNF receptor in TNF-induced adhesion molecule expression and leukocyte organ infiltration. J. Immunol. 156:1587-1593.
45. Ohmori, Y., L. Wyner, S. Narumi, D. Armstrong, M. Stoler, and T. A. Hamilton. 1993. Tumor necrosis factor-α induces cell type and tissue-specific expression of chemoattractant cytokines in vivo. Am. J. Pathol. 142:861-870.
46. Pasparakis, M., L. Alexopoulou, V. Episkopou, and G. Kollias. 1996. Immune and inflammatory responses in TNF-alpha-deficient mice: a critical requirement for TNF-alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. Proc. Natl. Acad. Sci. USA 184:1397-1411.
47. Qin, L., Y. Ding, D. R. Pahud, N. D. Robson, A. Shaked, and J. S. Bromberg. 1997. Adenovirus-mediated gene transfer of viral interleukin-10 inhibits the immune response to both alloantigen and adenoviral antigen. Hum. Gene Ther. 8:1365-1374.
48. Ryffel, B., F. Di Padova, M. H. Schreier, M. Le Hir, H.-P. Eugster, and V. F. J. Quesniaux. 1997. Lack of type 2 T cell-independent B cell responses and defect in isotype switching in TNF-lymphotoxin alpha-deficient mice. J. Immunol. 158:2126-2133.
49. Shisler, J., C. Yang, B. Walter, C. F. Ware, and L. R. Gooding. 1997. The adenovirus E3-10.4K/14.5K complex mediates loss of cell surface Fas (CD95) and resistance to Fas-induced apoptosis. J. Virol. 71:8299-8306.
50. Smith, T. A. G., B. D. White, J. M. Gardner, M. Kaleko, and A. McClelland. 1996. Transient immunosuppression permits successful repetitive intravenous administration of an adenovirus vector. Gene Ther. 3:496-502.
51. Sparer, T. E., R. A. Tripp, D. L. Dillehay, T. W. Hermiston, W. S. Wold, and L. R. Gooding. 1996. The role of human adenovirus early region 3 proteins (gp19k, 10.4K, 14.5K, and 14.7K) in a murine pneumonia model. J. Virol. 70: 2431-2439.
52. Starnes, H. F., M. K. Pearce, A. Tewari, J. H. Yim, J.-C. Zou, and J. S. Abrams. 1990. Anti-IL-6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal tumor necrosis factor-α challenge in mice. J. Immunol. 145:4185-4191.
53. Steel, D. M., and A. S. Whitehead. 1994. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol. Today 15:81-88.
54. Stratford-Perricaudet, L. D., I. Makeh, M. Perricaudet, and P. Briand. 1992. Widespread long-term gene transfer to mouse skeletal muscles and heart. J. Clin. Invest. 90:626-630.
55. Thimmappaya, B., C. Weinberger, R. J. Schneider, and T. Shenk. 1982. Adenovirus VAI RNA is required for efficient translation of viral mRNAs at late times after infection. Cell 31:543-551.
56. Tollefson, A. E., T. W. Hermiston, D. L. Lichtenstein, C. F. Colle, R. A. Tripp, T. Dimitrov, K. Toth, C. E. Wells, P. C. Doherty, and W. S. M. Wold. 1998. Forced degradation of Fas inhibits apoptosis in adenovirus-infected cells. Nature 392:726-729.
57. Tripathy, S. K., H. B. Black, E. Goldwasser, and J. Leiden. 1996. Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nat. Med. 2: 545-550.
58. Walter, J., Q. You, J. N. Hagstrom, M. Sands, and K. A. High. 1996. Successful expression of human factor IX following repeat administration of an adenoviral vector in mice. Proc. Natl. Acad. Sci. USA 93:3056-3061.
59. Wang, Q., G. Greenburg, D. Bunch, D. Farson, and M. H. Finer. 1997. Persistent transgene expression in mouse liver following in vivo gene transfer with a delta E1/delta E4 adenovirus vector. Gene Ther. 4:393-400.
60. Wolff, G., S. Worgall, N. van Rooijen, W.-R. Song, B.-G. Harvey, and R. G. Crystal. 1997. Enhancement of in vivo adenovirus-mediated gene transfer and expression by prior depletion of tissue macrophages in the target organ. J. Virol. 71:8798-8807.
61. Yang, Y., H. C. Ertl, and J. M. Wilson. 1994. MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 1:433-442.
62. Yang, Y., Q. Li, H. C. J. Ertl, and J. M. Wilson. 1995. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69:2004-2015.
63. Yang, Y., Q. Su, I. S. Grewal, R. Schilz, R. A. Flavell, and J. M. Wilson. 1996. Transient subversion of CD40 ligand function diminishes immune responses to adenovirus vectors in mouse liver and lung tissues. J. Virol. 70:6370-6377.
64. Yang, Y., G. Trinchieri, and J. M. Wilson. 1995. Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung. Nat. Med. 1:890-893.